BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21646916)

  • 1. A home-based maintenance therapy program for acute lymphoblastic leukemia-practical and safe?
    Phillips B; Richards M; Boys R; Hodgkin M; Kinsey S
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):433-6. PubMed ID: 21646916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital and home chemotherapy for children with leukemia: a randomized cross-over study.
    Stevens B; Croxford R; McKeever P; Yamada J; Booth M; Daub S; Gafni A; Gammon J; Greenberg M
    Pediatr Blood Cancer; 2006 Sep; 47(3):285-92. PubMed ID: 16200556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-related side effects in childhood acute lymphoblastic leukemia in Indonesia: parental perceptions.
    Sitaresmi MN; Mostert S; Purwanto I; Gundy CM; Sutaryo ; Veerman AJ
    J Pediatr Oncol Nurs; 2009; 26(4):198-207. PubMed ID: 19726791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of reduced chemotherapy treatment for good risk childhood acute lymphoblastic leukaemia on infectious morbidity*.
    van Tilburg CM; Sanders EA; Nibbelke EE; Pieters R; Revesz T; Westers P; Wolfs TF; Bierings MB
    Br J Haematol; 2011 Feb; 152(4):433-40. PubMed ID: 21223250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of maximum supportive care on dose compliance and survival. Single-center analysis of childhood acute lymphoblastic leukemia and non-Hodgkin's-lymphoma treated within 1984-1993.
    Urban C; Benesch M; Lackner H; Schwinger W; Kerbl R; Gadner H
    Klin Padiatr; 1997; 209(4):235-42. PubMed ID: 9293456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
    Schmiegelow K; Heyman M; Kristinsson J; Mogensen UB; Rosthøj S; Vettenranta K; Wesenberg F; Saarinen-Pihkala U;
    J Pediatr Hematol Oncol; 2009 Jun; 31(6):385-92. PubMed ID: 19648786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meeting the needs of parents around the time of diagnosis of disability among their children: evaluation of a novel program for information, support, and liaison by key workers.
    Rahi JS; Manaras I; Tuomainen H; Hundt GL
    Pediatrics; 2004 Oct; 114(4):e477-82. PubMed ID: 15466074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fitness of children with standard-risk acute lymphoblastic leukemia during maintenance therapy: response to a home-based exercise and nutrition program.
    Moyer-Mileur LJ; Ransdell L; Bruggers CS
    J Pediatr Hematol Oncol; 2009 Apr; 31(4):259-66. PubMed ID: 19346877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected].
    Magrath I; Shanta V; Advani S; Adde M; Arya LS; Banavali S; Bhargava M; Bhatia K; Gutiérrez M; Liewehr D; Pai S; Sagar TG; Venzon D; Raina V
    Eur J Cancer; 2005 Jul; 41(11):1570-83. PubMed ID: 16026693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing childhood leukaemia treatment before and after the introduction of a parental education programme in Indonesia.
    Mostert S; Sitaresmi MN; Gundy CM; Janes V; Sutaryo ; Veerman AJ
    Arch Dis Child; 2010 Jan; 95(1):20-5. PubMed ID: 19679573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How safe is triage by an after-hours telephone call center?
    Kempe A; Bunik M; Ellis J; Magid D; Hegarty T; Dickinson LM; Steiner JF
    Pediatrics; 2006 Aug; 118(2):457-63. PubMed ID: 16882795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, controlled evaluation of home chemotherapy for children with cancer.
    Close P; Burkey E; Kazak A; Danz P; Lange B
    Pediatrics; 1995 Jun; 95(6):896-900. PubMed ID: 7761218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia.
    Pession A; Valsecchi MG; Masera G; Kamps WA; Magyarosy E; Rizzari C; van Wering ER; Lo Nigro L; van der Does A; Locatelli F; Basso G; Aricò M
    J Clin Oncol; 2005 Oct; 23(28):7161-7. PubMed ID: 16192600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
    Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
    Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LISA: a web-based decision-support system for trial management of childhood acute lymphoblastic leukaemia.
    Bury J; Hurt C; Roy A; Cheesman L; Bradburn M; Cross S; Fox J; Saha V
    Br J Haematol; 2005 Jun; 129(6):746-54. PubMed ID: 15953000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
    van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
    Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Level of tau protein in children treated for acute lymphoblastic leukemia.
    Muszyńska-Rosłan K; Krawczuk-Rybak M; Protas PT; Hołownia A
    Pediatr Neurol; 2006 May; 34(5):367-71. PubMed ID: 16647996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute lymphoblastic leukemia in adolescents and young adults in Finland.
    Usvasalo A; Räty R; Knuutila S; Vettenranta K; Harila-Saari A; Jantunen E; Kauppila M; Koistinen P; Parto K; Riikonen P; Salmi TT; Silvennoinen R; Elonen E; Saarinen-Pihkala UM
    Haematologica; 2008 Aug; 93(8):1161-8. PubMed ID: 18556413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.
    Ribera JM; Oriol A; Sanz MA; Tormo M; Fernández-Abellán P; del Potro E; Abella E; Bueno J; Parody R; Bastida P; Grande C; Heras I; Bethencourt C; Feliu E; Ortega JJ
    J Clin Oncol; 2008 Apr; 26(11):1843-9. PubMed ID: 18398150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.